Introducing neoHUB, your comprehensive solution for navigating the complexities of cancer genomics and variant analysis. With a relentless focus on transforming raw data into actionable insights, neoHUB empowers researchers, clinicians, and laboratories with intuitive visualizations and powerful analytics tools.
Delve deeper into some of the key features of neoHUB.
Discover patient medical info and statistics on variants, neoantigens, TME, biomarkers, and HLA type.
Explore MHCI and MHCII neoantigens and scored peptide sequences for insights.
Learn about detected variants: SNVs, indels, gene fusions, neoisoforms, and transposable elements.
Compare patient sample with GTEx healthy tissues and TCGA tumors in differential expression analysis.
View HLA typing results from three techniques and expression patterns of MHC-associated genes.
Shows deconvolution results with nine cell fractions and quantifies uncharacterized cells.
Explore the depths of cancer genomics with neoHUB. Our platform stands out by offering powerful analytics and intuitive visualizations designed to transform complex data into actionable insights, ensuring you have the tools needed to make informed decisions in cancer research and treatment.
Subscribe to our newsletter
Get the latest news & updates about myNEO Therapeutics
Links
Cookie Statement
We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.
myNEO BV
Ottergemsesteenweg-Zuid 808 B511, 9000 Ghent, East-Flanders Belgium (BE0715710837)